Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28669
Title: Loss-of-function variants in Kv 11.1 cardiac channels as a biomarker for SUDEP.
Austin Authors: Soh, Ming S;Bagnall, Richard D;Bennett, Mark F ;Bleakley, Lauren E;Mohamed Syazwan, Erlina S;Phillips, A Marie;Chiam, Mathew D F;McKenzie, Chaseley E;Hildebrand, Michael S ;Crompton, Douglas;Bahlo, Melanie;Semsarian, Christopher;Scheffer, Ingrid E ;Berkovic, Samuel F ;Reid, Christopher A
Affiliation: The Florey Institute of Neuroscience and Mental Health
Epilepsy Research Centre
School of Biosciences, University of Melbourne, Melbourne, VIC, Australia
Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, VIC, Australia
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney, NSW, Australia
Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
Neurology Department, Northern Health, Epping, VIC, Australia
Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC, Australia
Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
Issue Date: Jul-2021
metadata.dc.date: 2021-05-18
Publication information: Annals of Clinical and Translational Neurology 2021; 8(7): 1422-1432
Abstract: To compare the frequency and impact on the channel function of KCNH2 variants in SUDEP patients with epilepsy controls comprising patients older than 50 years, a group with low SUDEP risk, and establish loss-of-function KCNH2 variants as predictive biomarkers of SUDEP risk. We searched for KCNH2 variants with a minor allele frequency of <5%. Functional analysis in Xenopus laevis oocytes was performed for all KCNH2 variants identified. KCNH2 variants were found in 11.1% (10/90) of SUDEP individuals compared to 6.0% (20/332) of epilepsy controls (p = 0.11). Loss-of-function KCNH2 variants, defined as causing >20% reduction in maximal amplitude, were observed in 8.9% (8/90) SUDEP patients compared to 3.3% (11/332) epilepsy controls suggesting about threefold enrichment (nominal p = 0.04). KCNH2 variants that did not change channel function occurred at a similar frequency in SUDEP (2.2%; 2/90) and epilepsy control (2.7%; 9/332) cohorts (p > 0.99). Rare KCNH2 variants (<1% allele frequency) associated with greater loss of function and an ~11-fold enrichment in the SUDEP cohort (nominal p = 0.03). In silico tools were unable to predict the impact of a variant on function highlighting the need for electrophysiological analysis. These data show that loss-of-function KCNH2 variants are enriched in SUDEP patients when compared to an epilepsy population older than 50 years, suggesting that cardiac mechanisms contribute to SUDEP risk. We propose that genetic screening in combination with functional analysis can identify loss-of-function KCNH2 variants that could act as biomarkers of an individual's SUDEP risk.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28669
DOI: 10.1002/acn3.51381
ORCID: 0000-0002-5689-2082
0000-0002-3561-6804
0000-0003-4580-841X
0000-0002-3638-2077
0000-0003-2739-0515
0000-0002-0776-1203
0000-0002-2311-2174
0000-0002-1457-8028
PubMed URL: 34002542
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/34002542/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.